Health IT corporation McKesson and retail giant Wal-Mart have signed a sourcing agreement for generic pharmaceuticals and an expanded long-term distribution agreement.
The organizations will collaborate on sourcing generic pharmaceuticals for their respective U.S. operations. The new sourcing agreement leverages McKesson's demonstrated strength and expertise in the global pharmaceutical industry and Wal-Mart's proven commitment to delivering high-quality and low-cost health and wellness services to its customers.
"McKesson and Wal-Mart have worked together for decades and throughout our relationship both companies have engaged in an ongoing dialogue about how we can work together to bring more efficiency and value to the healthcare supply chain," said Mark Walchirk, president of McKesson U.S. Pharmaceutical. "Expanding our relationship to include a sourcing partnership for generics makes economic and strategic sense for both of us — by bringing together our respective scale and sourcing expertise, we will make our businesses stronger and create more value for our customers and patients."